Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00435344 · ClinicalTrials.gov registry record · Phase 2
Provider and Peer Delivered Youth Smoking Intervention
A Phase 2 study of Tobacco Dependence, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,711
- Enrollment target
- 1
- Study location
NCT00435344 is a Phase 2 study of Tobacco Dependence that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 2,711 participants, above the 382-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (610% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00435344, a Phase 2 study of Tobacco Dependence, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,711 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to determine whether a pediatric practice-based smoking prevention and cessation intervention increases abstinence rates among adolescents.
Conditions Studied
Interventions
- BEHAVIORAL Pediatric Practice-Based Smoking Intervention
Study Locations (1)
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,711 participants |
| Start Date | 1999-02 |
| Est. Completion | 2004-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00435344
The ClinicalTrials.gov registry entry for NCT00435344 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,711 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 382-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (610% higher). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 1 intervention - of which Pediatric Practice-Based Smoking Intervention is the first listed.
NCT00435344 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00435344 about?
NCT00435344 is a clinical study titled "Provider and Peer Delivered Youth Smoking Intervention". The purpose of this study was to determine whether a pediatric practice-based smoking prevention and cessation intervention increases abstinence rates among adolescents.
What is the current status of trial NCT00435344?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,711 participants. The study started on 1999-02. Estimated completion is 2004-01.
What conditions does trial NCT00435344 study?
This clinical trial studies the following conditions: Tobacco Dependence.
What interventions are being tested in trial NCT00435344?
The interventions under investigation include: Pediatric Practice-Based Smoking Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00435344?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00435344 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
COMPLETED · Phase 2
-
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
COMPLETED · Phase 2
-
Harm Reduction for Smokers With Mental Illness
RECRUITING · NA
-
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
RECRUITING · Phase 3
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.